(Q36686034)

15 August 2017

1 reference

title

Regulation of smooth muscle cells in development and vascular disease: current therapeutic strategies (English)

1 reference

15 August 2017

1 reference

Xinjiang Cai

1

1 reference

15 August 2017

publication date

1 November 2006

1 reference

Expert Review of Cardiovascular Therapy

15 August 2017

published in

1 reference

15 August 2017

volume

4

1 reference

15 August 2017

issue

6

1 reference

15 August 2017

page(s)

789-800

1 reference

Pharmacological modulation of sarcoplasmic reticulum function in smooth muscle

15 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1586%2F14779072.4.6.789

Molecular regulation of vascular smooth muscle cell differentiation in development and disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.4.6.789

Inflammation in atherosclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.4.6.789

Heart disease and stroke statistics--2006 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.4.6.789

The ankle-brachial index in the elderly and risk of stroke, coronary disease, and death: the Framingham Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.4.6.789

Aortocoronary saphenous vein graft disease: pathogenesis, predisposition, and prevention

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.4.6.789

Peripheral arterial disease: identification and implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.4.6.789

Vascular proliferation and atherosclerosis: new perspectives and therapeutic strategies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.4.6.789

New therapeutic possibilities for vein graft disease in the post-edifoligide era.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.4.6.789

Atherosclerosis 2005: recent discoveries and novel hypotheses

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.4.6.789

Angiogenesis in health and disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.4.6.789

Heterozygous embryonic lethality induced by targeted inactivation of the VEGF gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.4.6.789

Molecular determinants of vascular smooth muscle cell diversity

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.4.6.789

Development of the coronary vessel system

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.4.6.789

Notch3 is required for arterial identity and maturation of vascular smooth muscle cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.4.6.789

Arterial smooth muscle cell heterogeneity: implications for atherosclerosis and restenosis development

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.4.6.789

Smooth muscle cells isolated from discrete compartments of the mature vascular media exhibit unique phenotypes and distinct growth capabilities.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.4.6.789

Innate diversity of adult human arterial smooth muscle cells: cloning of distinct subtypes from the internal thoracic artery

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.4.6.789

Myocardin and ternary complex factors compete for SRF to control smooth muscle gene expression.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.4.6.789

Novel embryonic genes are preferentially expressed by autonomously replicating rat embryonic and neointimal smooth muscle cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.4.6.789

Embryonic growth-associated protein is one subunit of a novel N-terminal acetyltransferase complex essential for embryonic vascular development

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.4.6.789

A heretical view on the role of NO and cGMP in vascular proliferative diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.4.6.789

Genetics of atherosclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.4.6.789

Inflammation, atherosclerosis, and coronary artery disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.4.6.789

Atherosclerosis in the apolipoprotein-E-deficient mouse: a decade of progress

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.4.6.789

Atherosclerotic plaque smooth muscle cells have a distinct phenotype

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.4.6.789

Smooth muscle progenitor cells in vascular disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.4.6.789

Origin of neointimal endothelium and alpha-actin-positive smooth muscle cells in transplant arteriosclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.4.6.789

Role of progenitor cells in transplant arteriosclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.4.6.789

Progenitor cells in vascular disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.4.6.789

Isolation of "side population" progenitor cells from healthy arteries of adult mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.4.6.789

Smooth muscle progenitor cells in human blood

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.4.6.789

Circulating monocytes and in-stent neointima after coronary stent implantation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.4.6.789

Smooth muscle cells in human coronary atherosclerosis can originate from cells administered at marrow transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.4.6.789

Vascular smooth muscle cells of recipient origin mediate intimal expansion after aortic allotransplantation in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.4.6.789

Murine model of neointimal formation and stenosis in vein grafts

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.4.6.789

Multi-year follow-up of abciximab therapy in three randomized, placebo-controlled trials of percutaneous coronary revascularization

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.4.6.789

The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels. Cholesterol and Recurrent Events Trial investigators

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.4.6.789

Molecular basis of restenosis and drug-eluting stents

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.4.6.789

Potent inhibitory effect of sirolimus on circulating vascular progenitor cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.4.6.789

Two-year angiographic and intravascular ultrasound follow-up after implantation of sirolimus-eluting stents in human coronary arteries

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.4.6.789

A randomized comparison of a sirolimus-eluting stent with a standard stent for coronary revascularization

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.4.6.789

Maintenance of long-term clinical benefit with sirolimus-eluting coronary stents: three-year results of the RAVEL trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.4.6.789

Two-year outcomes after sirolimus-eluting stent implantation: results from the Sirolimus-Eluting Stent in de Novo Native Coronary Lesions (SIRIUS) trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.4.6.789

Sirolimus-eluting stents remain superior to bare-metal stents at two years: medium-term results from the Rapamycin-Eluting Stent Evaluated at Rotterdam Cardiology Hospital (RESEARCH) registry.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.4.6.789

Sirolimus and Paclitaxel on polymer-based drug-eluting stents: similar but different

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.4.6.789

Pathology of drug-eluting stents in humans: delayed healing and late thrombotic risk.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.4.6.789

Vascular effects of sirolimus-eluting versus bare-metal stents in diabetic patients: three-dimensional ultrasound results of the Diabetes and Sirolimus-Eluting Stent (DIABETES) Trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.4.6.789

Treatment of saphenous vein graft lesions with drug-eluting stents: immediate and midterm outcome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.4.6.789

Local application of rapamycin inhibits neointimal hyperplasia in experimental vein grafts.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.4.6.789

Inhibition of neointimal hyperplasia in vascular grafts by sustained perivascular delivery of paclitaxel.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.4.6.789

E2F and cell cycle control: a double-edged sword

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.4.6.789

Transcription factor decoys: a new model for disease intervention

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.4.6.789

Inhibitory effects of NFkappaB decoy oligodeoxynucleotides on neointimal hyperplasia in a rabbit vein graft model

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.4.6.789

Administration of a decoy against the activator protein-1 binding site suppresses neointimal thickening in rabbit balloon-injured arteries

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.4.6.789

Long-term stabilization of vein graft wall architecture and prolonged resistance to experimental atherosclerosis after E2F decoy oligonucleotide gene therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.4.6.789

A gene therapy strategy using a transcription factor decoy of the E2F binding site inhibits smooth muscle proliferation in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.4.6.789

Ex-vivo gene therapy of human vascular bypass grafts with E2F decoy: the PREVENT single-centre, randomised, controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.4.6.789

Excess dosing of antiplatelet and antithrombin agents in the treatment of non-ST-segment elevation acute coronary syndromes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.4.6.789

Inhibition of fibroblast growth factor receptor signaling attenuates atherosclerosis in apolipoprotein E-deficient mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.4.6.789

Proliferation of neointimal smooth muscle cells after arterial injury. Dependence on interactions between fibroblast growth factor receptor-2 and fibroblast growth factor-9

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.4.6.789

Tyrphostins and other tyrosine kinase inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.4.6.789

PDGF receptor kinase inhibitors for the treatment of restenosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.4.6.789

Locally delivered nanoencapsulated tyrphostin (AGL-2043) reduces neointima formation in balloon-injured rat carotid and stented porcine coronary arteries.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.4.6.789

Platelet-derived growth factor-BB-induced human smooth muscle cell proliferation depends on basic FGF release and FGFR-1 activation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.4.6.789

Imatinib compared with interferon and low-dose cytarabine for newly diagnosed chronic-phase chronic myeloid leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.4.6.789

LRP: role in vascular wall integrity and protection from atherosclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.4.6.789

Imatinib attenuates diabetes-associated atherosclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.4.6.789

A randomized, double-blind, placebo-controlled trial on restenosis prevention by the receptor tyrosine kinase inhibitor imatinib

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.4.6.789

Randomized, double-blind, placebo-controlled trial of oral sirolimus for restenosis prevention in patients with in-stent restenosis: the Oral Sirolimus to Inhibit Recurrent In-stent Stenosis (OSIRIS) trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.4.6.789

Therapeutic potential of endothelial progenitor cells in cardiovascular diseases.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.4.6.789

Effect of vein graft harvesting on endothelial nitric oxide synthase and nitric oxide production

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.4.6.789

Mobilizing endothelial progenitor cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.4.6.789

The effect of stem cell mobilization by granulocyte-colony stimulating factor on neointimal hyperplasia and endothelial healing after vascular injury with bare-metal versus paclitaxel-eluting stents.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.4.6.789

Accelerated arteriosclerosis of vein grafts in inducible NO synthase(-/-) mice is related to decreased endothelial progenitor cell repair

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.4.6.789

Local gene transfer of phVEGF-2 plasmid by gene-eluting stents: an alternative strategy for inhibition of restenosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.4.6.789

A novel drug-eluting stent coated with an integrin-binding cyclic Arg-Gly-Asp peptide inhibits neointimal hyperplasia by recruiting endothelial progenitor cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.4.6.789

Influence of cardiovascular risk factors on endothelial progenitor cells: limitations for therapy?

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.4.6.789

The cation/Ca(2+) exchanger superfamily: phylogenetic analysis and structural implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.4.6.789

Excitation-transcription coupling in arterial smooth muscle.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.4.6.789

Excitation-transcription coupling in smooth muscle

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.4.6.789

Calcineurin initiates smooth muscle differentiation in neural crest stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.4.6.789

L-type voltage-gated Ca2+ channels modulate expression of smooth muscle differentiation marker genes via a rho kinase/myocardin/SRF-dependent mechanism.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.4.6.789

Novel vascular biology of third-generation L-type calcium channel antagonists: ancillary actions of amlodipine

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.4.6.789

Benidipine, a calcium channel blocker, regulates proliferation and phenotype of vascular smooth muscle cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.4.6.789

Blockade of the intermediate-conductance calcium-activated potassium channel as a new therapeutic strategy for restenosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.4.6.789

Upregulated TRPC1 channel in vascular injury in vivo and its role in human neointimal hyperplasia

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.4.6.789

Sarco/endoplasmic reticulum Ca2+-ATPase gene transfer reduces vascular smooth muscle cell proliferation and neointima formation in the rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.4.6.789

Modulation of phosphatidylinositol 3-kinase signaling reduces intimal hyperplasia in aortocoronary saphenous vein grafts.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.4.6.789

Adenovirus-mediated intraarterial delivery of PTEN inhibits neointimal hyperplasia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.4.6.789

iNOS gene transfer for graft disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.4.6.789

Stent-based delivery of tissue inhibitor of metalloproteinase-3 adenovirus inhibits neointimal formation in porcine coronary arteries.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.4.6.789

Vein graft neointimal hyperplasia is exacerbated by tumor necrosis factor receptor-1 signaling in graft-intrinsic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.4.6.789

Anti-MCP-1 gene therapy inhibits vascular smooth muscle cells proliferation and attenuates vein graft thickening both in vitro and in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.4.6.789

Cadherin:catenin complex: a novel regulator of vascular smooth muscle cell behaviour

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.4.6.789

Oral imatinib mesylate (STI571/gleevec) improves the efficacy of local intravascular vascular endothelial growth factor-C gene transfer in reducing neointimal growth in hypercholesterolemic rabbits

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.4.6.789

Knocking down disease with siRNAs

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.4.6.789

Gene expression analysis of cardiovascular diseases: novel insights into biology and clinical applications

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.4.6.789

Biology of atherosclerotic plaques: what we are learning from proteomic analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.4.6.789

Circulating bone marrow cells can contribute to neointimal formation

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.4.6.789

Flk1-positive cells derived from embryonic stem cells serve as vascular progenitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.4.6.789

21 January 2018

Identifiers

DOI

10.1586/14779072.4.6.789

1 reference

15 August 2017

1 reference